VEMLIDY
tenofovir alafenamide
Listed by Gilead Sciences, Inc.
- Strength
- 25 mg/1
- Form
- Tablet
- Route
- Oral
- Class
- Hepatitis B Virus Nucleoside Analog Reverse T…
What it contains
- Tenofovir Alafenamide Fumarate 25 mg/1
FDA record
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 61958-2301 |
| FDA application | NDA208464 |
| RxNorm concept | 1858261 |
| Package sizes listed | 1 |
| Marketed since | November 2016 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.